Moderna takes aim at global expansion plans with manufacturing ramp-up - Pharmaceutical Technology
Moderna CEO Stephane Bancel Says He'll Give Most of His Money Away (MRNA) - Bloomberg
Moderna should do its part, share its vaccine - CommonWealth Magazine
Why Are Moderna Executives Selling Stock While Developing A Coronavirus Vaccine? : NPR
Moderna eyes Covid-19, flu booster by 2023
Moderna CEO to testify in senate on proposed vaccine price hike | Reuters
Moderna CEO Stephane Bancel on the outlook for the extending timeline of mRNA technology efficacy - YouTube
Moderna CEO Stéphane Bancel gets a $1.2M bump in pay to $19.4M
Stéphane Bancel: Moderna's $5bn man
The Interview: Moderna CEO Stéphane Bancel
Moderna COVID vaccine: CEO Stéphane Bancel says the company is working toward a single shot for both COVID, flu protection | Fortune
/cloudfront-us-east-1.images.arcpublishing.com/bostonglobe/P733R6KEKRD4TICGY4FYWJDC2U.jpg "Moderna prepares for transition year as COVID vaccine sales wane, CEO says. - The Boston Globe")
Moderna prepares for transition year as COVID vaccine sales wane, CEO says. - The Boston Globe
Moderna CEO Bancel Says He'll Give Most of His Money Away | Wealth Management
Stéphane Bancel | Nature Reviews Drug Discovery
Stéphane Bancel (Moderna): "Nous sommes prêts à vacciner" - Challenges
Moderna. Stéphane Bancel, le nouveau riche qui assure ne pas s'intéresser à l'argent | L'Humanité
Moderna says its COVID vaccine will remain free for all consumers, even those uninsured - ABC News
Interview with Stéphane Bancel | Science History Institute
Inside Moderna Therapeutics, biotech's most secretive startup
2021 Most Influential in Healthcare Stéphane Bancel | Modern Healthcare
Moderna CEO Bancel to testify before Senate on Covid vaccine price hike
Moderna : Stéphane Bancel entre dans la cour des philanthropes | Les Echos
Moderna CEO Stephane Bancel has sold more than $400 million of company stock during the pandemic
Stéphane Bancel, Moderna Therapeutics
Moderna's CEO says he 'didn't lose a minute of sleep' over potential waiver of vaccine patents - The Boston Globe
Le patron de Moderna va faire don des ventes de ses stock-options à des œuvres de bienfaisance
